Posted by Michael Wonder on 17 Nov 2022
NICE recommends 3 treatments for COVID-19 in draft guidance
16 November 2022 - Three treatments for COVID have been recommended in draft NICE guidance released today for public consultation.
The recommended treatments are:
- Nirmatrelvir and ritonavir (Paxlovid, Pfizer)
- Tocilizumab (RoActemra, Roche)
- Baricitinib (Olumiant, Eli Lilly, subject to it receiving a marketing authorisation in Great Britain for treating COVID-19)
